BAUSCH + LOMB CORP (BLCO) Fundamental Analysis & Valuation

NYSE:BLCO • CA0717051076

16.2 USD
-0.38 (-2.29%)
At close: Mar 13, 2026
16.2 USD
0 (0%)
After Hours: 3/13/2026, 8:11:51 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This BLCO fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to BLCO. BLCO was compared to 184 industry peers in the Health Care Equipment & Supplies industry. BLCO has a medium profitability rating, but doesn't score so well on its financial health evaluation. BLCO has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. BLCO Profitability Analysis

1.1 Basic Checks

  • In the past year BLCO was profitable.
  • BLCO had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: BLCO reported negative net income in multiple years.
  • Of the past 5 years BLCO 4 years had a positive operating cash flow.
BLCO Yearly Net Income VS EBIT VS OCF VS FCFBLCO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M 600M 800M

1.2 Ratios

  • BLCO has a Return On Assets of -2.57%. This is in the better half of the industry: BLCO outperforms 69.57% of its industry peers.
  • Looking at the Return On Equity, with a value of -5.58%, BLCO is in the better half of the industry, outperforming 70.11% of the companies in the same industry.
  • With a decent Return On Invested Capital value of 1.23%, BLCO is doing good in the industry, outperforming 67.39% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for BLCO is significantly below the industry average of 9.18%.
Industry RankSector Rank
ROA -2.57%
ROE -5.58%
ROIC 1.23%
ROA(3y)-2.29%
ROA(5y)-1.02%
ROE(3y)-4.76%
ROE(5y)-2.45%
ROIC(3y)1.34%
ROIC(5y)1.76%
BLCO Yearly ROA, ROE, ROICBLCO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 0 2 -2 -4

1.3 Margins

  • With a decent Operating Margin value of 3.69%, BLCO is doing good in the industry, outperforming 68.48% of the companies in the same industry.
  • In the last couple of years the Operating Margin of BLCO has declined.
  • BLCO has a Gross Margin of 59.81%. This is in the better half of the industry: BLCO outperforms 60.33% of its industry peers.
  • BLCO's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 3.69%
PM (TTM) N/A
GM 59.81%
OM growth 3Y-17.35%
OM growth 5Y-14.11%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.07%
GM growth 5Y-0.82%
BLCO Yearly Profit, Operating, Gross MarginsBLCO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. BLCO Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BLCO is destroying value.
  • Compared to 1 year ago, BLCO has more shares outstanding
  • BLCO has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, BLCO has a worse debt to assets ratio.
BLCO Yearly Shares OutstandingBLCO Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
BLCO Yearly Total Debt VS Total AssetsBLCO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 5B 10B

2.2 Solvency

  • BLCO has an Altman-Z score of 0.87. This is a bad value and indicates that BLCO is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 0.87, BLCO is in line with its industry, outperforming 48.91% of the companies in the same industry.
  • A Debt/Equity ratio of 0.78 indicates that BLCO is somewhat dependend on debt financing.
  • BLCO has a worse Debt to Equity ratio (0.78) than 70.11% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF N/A
Altman-Z 0.87
ROIC/WACC0.12
WACC9.88%
BLCO Yearly LT Debt VS Equity VS FCFBLCO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B

2.3 Liquidity

  • BLCO has a Current Ratio of 1.55. This is a normal value and indicates that BLCO is financially healthy and should not expect problems in meeting its short term obligations.
  • BLCO's Current ratio of 1.55 is on the low side compared to the rest of the industry. BLCO is outperformed by 73.37% of its industry peers.
  • BLCO has a Quick Ratio of 1.04. This is a normal value and indicates that BLCO is financially healthy and should not expect problems in meeting its short term obligations.
  • BLCO's Quick ratio of 1.04 is on the low side compared to the rest of the industry. BLCO is outperformed by 76.09% of its industry peers.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 1.04
BLCO Yearly Current Assets VS Current LiabilitesBLCO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. BLCO Growth Analysis

3.1 Past

  • BLCO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -19.35%.
  • The Revenue has been growing slightly by 6.47% in the past year.
  • BLCO shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.38% yearly.
EPS 1Y (TTM)-19.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28%
Revenue 1Y (TTM)6.47%
Revenue growth 3Y10.62%
Revenue growth 5Y8.38%
Sales Q2Q%9.77%

3.2 Future

  • Based on estimates for the next years, BLCO will show a very strong growth in Earnings Per Share. The EPS will grow by 29.28% on average per year.
  • BLCO is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.41% yearly.
EPS Next Y61.57%
EPS Next 2Y47.88%
EPS Next 3Y40.86%
EPS Next 5Y29.28%
Revenue Next Year6.99%
Revenue Next 2Y6.25%
Revenue Next 3Y5.95%
Revenue Next 5Y5.41%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BLCO Yearly Revenue VS EstimatesBLCO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2B 4B 6B
BLCO Yearly EPS VS EstimatesBLCO Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0.5 1 1.5 2

More info and screens

Find the best growth stocksShow best growing peers

4

4. BLCO Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 32.40, which means the current valuation is very expensive for BLCO.
  • Based on the Price/Earnings ratio, BLCO is valued a bit cheaper than 71.20% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 25.70. BLCO is valued slightly more expensive when compared to this.
  • The Price/Forward Earnings ratio is 20.05, which indicates a rather expensive current valuation of BLCO.
  • Based on the Price/Forward Earnings ratio, BLCO is valued a bit cheaper than 76.63% of the companies in the same industry.
  • BLCO is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.84, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 32.4
Fwd PE 20.05
BLCO Price Earnings VS Forward Price EarningsBLCO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, BLCO is valued a bit cheaper than 75.54% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 17.36
BLCO Per share dataBLCO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as BLCO's earnings are expected to grow with 40.86% in the coming years.
PEG (NY)0.53
PEG (5Y)N/A
EPS Next 2Y47.88%
EPS Next 3Y40.86%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BLCO Dividend Analysis

5.1 Amount

  • BLCO does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BLCO Fundamentals: All Metrics, Ratios and Statistics

BAUSCH + LOMB CORP

NYSE:BLCO (3/13/2026, 8:11:51 PM)

After market: 16.2 0 (0%)

16.2

-0.38 (-2.29%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-18
Earnings (Next)N/A
Inst Owners10.27%
Inst Owner Change3.1%
Ins Owners0.48%
Ins Owner Change17.19%
Market Cap5.74B
Revenue(TTM)5.10B
Net Income(TTM)-360.00M
Analysts71.58
Price Target18.83 (16.23%)
Short Float %8.18%
Short Ratio8.23
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.14%
Min EPS beat(2)-10.76%
Max EPS beat(2)8.47%
EPS beat(4)2
Avg EPS beat(4)-90.21%
Min EPS beat(4)-360.35%
Max EPS beat(4)8.47%
EPS beat(8)5
Avg EPS beat(8)-43.92%
EPS beat(12)8
Avg EPS beat(12)-25.31%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.1%
Min Revenue beat(2)-1.91%
Max Revenue beat(2)-0.28%
Revenue beat(4)0
Avg Revenue beat(4)-1.41%
Min Revenue beat(4)-3.07%
Max Revenue beat(4)-0.28%
Revenue beat(8)2
Avg Revenue beat(8)-0.31%
Revenue beat(12)5
Avg Revenue beat(12)0.68%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)6.49%
PT rev (3m)7.6%
EPS NQ rev (1m)-30.89%
EPS NQ rev (3m)-47.56%
EPS NY rev (1m)0.36%
EPS NY rev (3m)2.02%
Revenue NQ rev (1m)0.81%
Revenue NQ rev (3m)0.73%
Revenue NY rev (1m)1.13%
Revenue NY rev (3m)1.15%
Valuation
Industry RankSector Rank
PE 32.4
Fwd PE 20.05
P/S 1.13
P/FCF N/A
P/OCF 20.28
P/B 0.89
P/tB N/A
EV/EBITDA 17.36
EPS(TTM)0.5
EY3.09%
EPS(NY)0.81
Fwd EY4.99%
FCF(TTM)-0.19
FCFYN/A
OCF(TTM)0.8
OCFY4.93%
SpS14.4
BVpS18.2
TBVpS-4.49
PEG (NY)0.53
PEG (5Y)N/A
Graham Number14.31
Profitability
Industry RankSector Rank
ROA -2.57%
ROE -5.58%
ROCE 1.55%
ROIC 1.23%
ROICexc 1.27%
ROICexgc 4.04%
OM 3.69%
PM (TTM) N/A
GM 59.81%
FCFM N/A
ROA(3y)-2.29%
ROA(5y)-1.02%
ROE(3y)-4.76%
ROE(5y)-2.45%
ROIC(3y)1.34%
ROIC(5y)1.76%
ROICexc(3y)1.38%
ROICexc(5y)1.81%
ROICexgc(3y)4.6%
ROICexgc(5y)6.09%
ROCE(3y)1.7%
ROCE(5y)2.22%
ROICexgc growth 3Y-15.27%
ROICexgc growth 5Y-11.42%
ROICexc growth 3Y-14.77%
ROICexc growth 5Y-9.61%
OM growth 3Y-17.35%
OM growth 5Y-14.11%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.07%
GM growth 5Y-0.82%
F-Score3
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF N/A
Debt/EBITDA 8.28
Cap/Depr 82.9%
Cap/Sales 6.84%
Interest Coverage 0.49
Cash Conversion 46.47%
Profit Quality N/A
Current Ratio 1.55
Quick Ratio 1.04
Altman-Z 0.87
F-Score3
WACC9.88%
ROIC/WACC0.12
Cap/Depr(3y)65.67%
Cap/Depr(5y)57.94%
Cap/Sales(3y)5.76%
Cap/Sales(5y)5.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-19.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28%
EPS Next Y61.57%
EPS Next 2Y47.88%
EPS Next 3Y40.86%
EPS Next 5Y29.28%
Revenue 1Y (TTM)6.47%
Revenue growth 3Y10.62%
Revenue growth 5Y8.38%
Sales Q2Q%9.77%
Revenue Next Year6.99%
Revenue Next 2Y6.25%
Revenue Next 3Y5.95%
Revenue Next 5Y5.41%
EBIT growth 1Y-7.39%
EBIT growth 3Y-8.57%
EBIT growth 5Y-6.91%
EBIT Next Year65.28%
EBIT Next 3Y27.94%
EBIT Next 5Y20.35%
FCF growth 1Y-11.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y21.98%
OCF growth 3Y-6.39%
OCF growth 5Y-11.52%

BAUSCH + LOMB CORP / BLCO FAQ

What is the fundamental rating for BLCO stock?

ChartMill assigns a fundamental rating of 3 / 10 to BLCO.


What is the valuation status of BAUSCH + LOMB CORP (BLCO) stock?

ChartMill assigns a valuation rating of 4 / 10 to BAUSCH + LOMB CORP (BLCO). This can be considered as Fairly Valued.


Can you provide the profitability details for BAUSCH + LOMB CORP?

BAUSCH + LOMB CORP (BLCO) has a profitability rating of 4 / 10.


What is the financial health of BAUSCH + LOMB CORP (BLCO) stock?

The financial health rating of BAUSCH + LOMB CORP (BLCO) is 1 / 10.